CAPSTONE INVESTMENT ADVISORS, LLC - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 160 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2016. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAPSTONE INVESTMENT ADVISORS, LLC ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q4 2017$303,000
-46.9%
2,900
-43.9%
0.01%
-25.0%
Q3 2016$571,000
-55.4%
5,168
-41.3%
0.01%
-50.0%
Q2 2016$1,281,0008,8010.02%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q2 2016
NameSharesValueWeighting ↓
Claret Asset Management Corp 86,474$6,524,0001.34%
Analyst IMS Investment Management Services Ltd. 28,438$2,143,0000.64%
ALGERT GLOBAL LLC 20,876$1,575,0000.59%
Quantinno Capital Management LP 9,351$706,0000.48%
Crestline Management, LP 37,000$2,792,0000.45%
Empirical Finance, LLC 9,561$721,0000.20%
BRANDES INVESTMENT PARTNERS, LP 55,065$5,469,0000.14%
FORT, L.P. 9,672$730,0000.14%
CAXTON ASSOCIATES LP 8,865$669,0000.13%
ACADIAN ASSET MANAGEMENT LLC 330,448$24,928,0000.11%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders